tradingkey.logo

tradingkey.logo
怜玢


Femasys Inc

FEMY
りォッチリストに远加
1.420USD
+0.020+1.43%
終倀 11-13 16:00ET
11.90M時䟡総額
損倱額盎近12ヶ月PER

Femasys Incに぀いお 䌁業名

Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.

Femasys Inc プロフィヌル


䌁業コヌドFEMY
䌚瀟名Femasys Inc
䞊堎日Jun 18, 2021
最高経営責任者「CEO」Lee-Sepsick (Kathy)
埓業員数69
蚌刞皮類Ordinary Share
決算期末Jun 18
本瀟所圚地3950 Johns Creek Court
郜垂SUWANEE
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号30024
電話番号17705003910
りェブサむトhttps://www.femasys.com/
䌁業コヌドFEMY
䞊堎日Jun 18, 2021
最高経営責任者「CEO」Lee-Sepsick (Kathy)

Femasys Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Kathy Lee-Sepsick
Ms. Kathy Lee-Sepsick
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
37.27K
+41.93%
Mr. John Canning
Mr. John Canning
Chief Operating Officer
Chief Operating Officer
5.88K
+74.47%
Dr. Kenneth D. Eichenbaum, M.D.
Dr. Kenneth D. Eichenbaum, M.D.
Independent Director
Independent Director
1.25K
--
Ms. Kelley Nicholas
Ms. Kelley Nicholas
Chief Commercial Officer
Chief Commercial Officer
4.00
--
Mr. Daniel Currie
Mr. Daniel Currie
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Charles E. Larsen
Mr. Charles E. Larsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Edward Uzialko, Jr.
Mr. Edward Uzialko, Jr.
Independent Director
Independent Director
--
--
Mr. Dov Elefant
Mr. Dov Elefant
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Christine Thomas
Ms. Christine Thomas
Chief Regulatory and Clinical Officer
Chief Regulatory and Clinical Officer
--
--
Mr. Alistair Milnes
Mr. Alistair Milnes
Independent Director
Independent Director
--
-100.00%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Kathy Lee-Sepsick
Ms. Kathy Lee-Sepsick
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
37.27K
+41.93%
Mr. John Canning
Mr. John Canning
Chief Operating Officer
Chief Operating Officer
5.88K
+74.47%
Dr. Kenneth D. Eichenbaum, M.D.
Dr. Kenneth D. Eichenbaum, M.D.
Independent Director
Independent Director
1.25K
--
Ms. Kelley Nicholas
Ms. Kelley Nicholas
Chief Commercial Officer
Chief Commercial Officer
4.00
--
Mr. Daniel Currie
Mr. Daniel Currie
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Charles E. Larsen
Mr. Charles E. Larsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--

よくある質問

Femasys Incの䞊䜍5名の株䞻は誰ですか


Femasys Incの䞊䜍5名の株䞻は以䞋のずおりです。Ms. Kathy Lee-Sepsick

Femasys IncFEMYの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Femasys Incの株匏を保有しおいる機関は64瀟あり、保有株匏の総垂堎䟡倀は玄6.18Mで、党䜓の10.23%を占めおいたす。2025Q4ず比范しお、機関の持ち株は1191594.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。